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Abstract A new screening method for the detection and
identification of GMO, based on the use of multiplex PCR
followed by microarray, has been developed and is pre-
sented. The technology is based on the identification of quite
ubiquitous GMO genetic target elements first amplified by
PCR, followed by direct hybridisation of the amplicons on a
predefined microarray (DualChip GMO, Eppendorf, Ger-
many). The validation was performed within the framework
of a European project (Co-Extra, contract no 007158) and in
collaboration with 12 laboratories specialised in GMO
detection. The present study reports the strategy and the
results of an ISO complying validation of the method carried
out through an inter-laboratory study. Sets of blind samples
were provided consisting of DNA reference materials cov-
ering all the elements detectable by specific probes present
on the array. The GMO concentrations varied from 1% down
to 0.045%. In addition, a mixture of two GMO events (0.1%
RRS diluted in 100% TOPAS19/2) was incorporated in the
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study to test the robustness of the assay in extreme condi-
tions. Data were processed according to ISO 5725 standard.
The method was evaluated with predefined performance
criteria with respect to the EC CRL method acceptance
criteria. The overall method performance met the accep-
tance criteria; in particular, the results showed that the
method is suitable for the detection of the different target
elements at 0.1% concentration of GMO with a 95% accu-
racy rate. This collaborative trial showed that the method
can be considered as fit for the purpose of screening with
respect to its intra- and inter-laboratory accuracy. The
results demonstrated the validity of combining multiplex
PCR with array detection as provided by the DualChip
GMO (Eppendorf, Germany) for the screening of GMO. The
results showed that the technology is robust, practical and
suitable as a screening tool.
Keywords GMO  DualChip GMO  Microarray 
Screening  Multiplex  Validation  PCR 
Inter-laboratory ring trial
Abbreviation
CRL Community Reference Laboratory
EC European Commission
PCR Polymerase Chain Reaction
Introduction
In recent years, the presence of genetically modified
organisms (GMOs) in food and animal feed has increased
dramatically. Although different countries, such as the USA,
consider GMOs as substantially equivalent to non-GMO
food and therefore do not require any specific labelling of
products containing or deriving from approved GMOs,
several other countries enforce the labelling of such products
above a threshold level. These adventitious presence
thresholds are fixed at 1% in Australia and New Zealand, 3%
in South Korea, 4% in Brazil and 5% in Japan, Taiwan and
Thailand. To ensure the consumer’s choice of freedom, the
European Union implemented mandatory rules for labelling
food and feed containing GMOs or derived thereof above a
threshold of 0.9% with a requirement for the traceability of
the GMO in the food and feed chains [1, 2]. In 2006, 26
GMO events were accepted for commercialisation in the
EU, of which 24 were plant species. Five of these GMOs are
subjected to special restrictions of use within the EU (http://
ec.europa.eu/food/dyna/gm_register/index_en.cfm). There-
fore, the availability of reliable and validated methods to
detect the presence of GMO(s) is a clear necessity.
Until now, validated methods are based on simplex
detection, most of them in real-time PCR, focussing on the
most common GMOs present in the market or accepted in
different countries (http://bgmo.jrc.ec.europa.eu/home/
docs.htm). Many methods for GMO testing have been
developed, mostly based on PCR or real-time PCR [3–8].
However, the recent increased number of approved GMOs
and the outbreaks in Europe of unapproved GMOs raised the
need of screening strategies to identify the approved GMOs
and to differentiate them from non-approved ones. As a
consequence, it becomes essential to develop tests for a
reliable and simultaneously specific detection of multiple
target elements in a single assay.
Following the valuable results obtained with the
GMOChip [9], a new biochip (DualChip GMO, Ep-
pendorf, Germany) was developed for the detection and
identification of the EU approved GMOs.
Detection of the amplicons produced by PCR is
achieved by their direct hybridisation to capture probes
present in spots on a predefined array [10]. The strength of
the microarray results from the possibility to obtain mul-
tiple detections in one assay, thanks to the presence of
multiple capture probes specific for each of the different
targets (see the former European GMOchips research
program). The present method is based on the detection of
individual small GMO-specific DNA sequences, such as
promoters, terminators, inserted genes and reference genes
for taxa identification rather than on long inserted frag-
ments as in Leimanis et al. 2006 [9].
The detection of these small specific sequences called
GM elements is then used as a signature of the GM event.
Practically, an algorithm compares the pattern of these
elements with a data composition of the EU authorised
GM in a ‘‘matrix approach’’ and the correspondence of the
experimental data with the genetic composition of the GM
allows a unique or restricted identification of the GM
event.
Different performance criteria were predefined and first
tested in a pre-validation study performed in five different
laboratories. Based on the positive results of the pre-vali-
dation, the acceptance criteria were confirmed and the
inter-laboratory ring trial was organised. The goal of this
study was to assess the performance of the DualChip
GMO assay as a screening method through a collaborative
study. The validation of this detection method was con-
ducted according to ISO 5725 norm and performed in 12
laboratories from different countries with quality assurance
systems in place.
Materials and methods
Samples
GMO certified reference materials (CRM) (Maize Bt176,
Maize MON810, Maize Bt11 and Roundup ReadyTM Soya)
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and the non-GMO plants produced by the Institute for
Reference Materials and Measurement (IRMM, Belgium)
were purchased from Fluka (Switzerland). The certified
concentration value of these CRM is merely based on the
mass fraction of GMO to non-GMO dry powder. Control
samples of rapeseed TOPAS 19/2 were provided by Bayer
BioSciences (Belgium). GA21 Maize seeds were the same
as described in Leimanis et al. 2006 [9].
For the validation of the method, test samples were
provided to each participating laboratory as blind samples
consisting of DNA reference samples specifically adapted
to each GM element. The samples were delivered with
different concentrations enabling sensitivity testing of the
assays. A total of 36 unknown samples, representing six
GM levels and five plant DNA levels (see Table 1) were
used in the validation study.
All the GMO and non-transgenic plant samples used in
the different PCR sets (see Table 1) were prepared from
DNA (at concentration of 20 ng/ll) extracted from the
certified reference materials by dilution in the pENGL
buffer. This buffer contains 20 ng/ll genomic calf thymus
DNA (average molecular weight peaking at 5 Kbases) in
Tris/HCl 10 mM, pH 7.5, EDTA 1 mM. The use of the
pENGL buffer allowed saving large amount of non-trans-
genic plant DNA. The concentrations in GMO and plant
are expressed hereafter in percentage of total DNA present
in the sample and not in percentage per ingredient (see
Table 1).
Practically, all the single ingredient DNA samples (see
following samples in Table 1: 1, 2, 4–11 and 20–23) were
prepared with DNA extracted from certified reference
materials at 5% by diluting in pENGL buffer to obtain
lower concentrations in GMO (1, 0.5, 0.1 and 0.045%).
Samples containing several GMOs (samples: 12–15 and
28–31) were prepared in the same way using pENGL
buffer. Maize samples (samples: 16–19) were obtained
from pure non-transgenic maize DNA by dilution in the
pENGL buffer. Sample 32 containing both rapeseed and
soybean at 50% was prepared by mixing identical volumes
of both non-transgenic plant DNA (both at 20 ng/ll).
Lower concentrations (samples: 33 to 35) were obtained by
dilution in pENGL buffer. Sample 36 was prepared by a 50
times dilution of DNA extracted from the 5% CRM of RRS
in pure transgenic DNA of TOPAS19/2. Sample 3 is
composed of 100 ng of non-plant DNA.
DNA extraction
Genomic DNA was extracted using a CTAB-based method
[11]. The genomic DNA was quantified using the ‘‘Quant-
itTM PicoGreen dsDNA assay kit’’ (Invitrogen, USA) as
described in the manual.
Table 1 Composition of the four PCR (A, B, C, D) in the different PCR sets used for the validation
PCR set Samples in PCR tubes
Reaction tube A (A) Reaction tube B(B) Reaction tube C(C) Reaction tube D (D)
PCR1a 0.1% RRS (1) 0.1% RRS (1) 0.1% RRS (1) 2% soybean (1)
PCR1b 0.1% Bt176 (2) 0.1% Bt176 (2) 0.1% Bt176 (2) 2% maize (2)
PCR2a Non-plant DNA (3) Non-plant DNA (3) Non-plant DNA (3) Non-plant DNA (3)
PCR3a 1% Bt11 (4) 1% TOPAS19/2 (8) 1% RRS + 1% Bt11 + 1%
MON810 (12)
50% maize (16)
PCR3b 0.5% Bt11 (5) 0.5% TOPAS19/2 (9) 0.5% RRS + 0.5% Bt11 + 0.5%
MON810 (13)
5% maize (17)
PCR4a 0.1% Bt11 (6) 0.1% TOPAS19/2 (10) 0.1% RRS + 0.1% Bt11 + 0.1%
MON810 (14)
1% maize (18)
PCR4b 0.045% Bt11 (7) 0.045% TOPAS19/2 (11) 0.045% RRS + 0.045%
Bt11 + 0.045% MON810 (15)
0.5% maize (19)
PCR5a 1% Bt176 (20) CaMV (500 copies of
plasmid) (24)
1% Bt176 + 1% GA21 (28) 50% rapeseed + 50%
soybean (32)
PCR5b 0.5% Bt176 (21) CaMV (100 copies of
plasmid) (25)
0.5% Bt176 + 0.5% GA21 (29) 5% rapeseed + 5%
soybean (33)
PCR6a 0.1% Bt176 (22) CaMV (50 copies of
plasmid) (26)
0.1% Bt176 + 0.1% GA21 (30) 1% rapeseed + 1%
soybean (34)
PCR6b 0.045% Bt176 (23) CaMV (20 copies of
plasmid) (27)
0.045% Bt176 + 0.045% GA21
(31)
0.5% rapeseed + 0.5%
soybean (35)
PCR7a 0.1% RRS in 100%
TOPAS19/2 (36)
0.1% RRS in 100%
TOPAS19/2 (36)
0.1% RRS in 100% TOPAS19/2
(36)
2% soybean in 100%
rapeseed (36)
Concentrations of GMO and plant are expressed in percentage of total DNA. A number is given for each sample and placed in brackets after the
name of the sample. Amplicons from the four A, B, C, D PCR tubes were mixed for the hybridisation on microarray
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Assay
The PCR, hybridisation and detection were performed
according to the instructions of the DualChip GMO kit
(Eppendorf, Hamburg, Germany).
Microarray composition
The microarray consists of a glass slide with capture probes
spotted in triplicates on the slide according to a specific
pattern that is recognised by the data analysis software. The
nucleotide sequences are covalently attached by an amino
group at the 50 end onto an aldehyde functionalised slide
[12]. The design of the chip with the location of the dif-
ferent probes present on the array is presented in Fig. 1.
The different capture probes present on the microarray
are the following: P35S and Tnos capture probes allow the
detection of small DNA fragments present in most GMOs.
For example, the P35S capture probe recognises a small
conserved part of the CaMV 35S promoter sequence,
which is present in at least all EU-accepted GMOs having a
35S promoter. The Pnos-nptII capture probe is specific to a
construct-specific sequence present in only 3 (TOPAS19/2,
MS1xRF1 and MS1xRF2) out of the 24 GMOs, which are
accepted in Europe. Capture probe of EPSPS-2 allows
the detection of a specific sequence present in RRS and
Capture 
probe
Target sequence 
  ecneuqes retomorp S53 VMaC eht fo trap devresnoC S53P
 rotanimret esahtnys enilapoN sonT
Pnos-nptII Junction region between the nopaline synthase promoter and the neomycin phosphotransferase II
gene
EPSPS-1 5-enolpyruvylshikimate-3-phosphate synthase specific to the sequence present in GA21 
EPSPS-2 5-enolpyruvylshikimate-3-phosphate synthase specific to the sequence present in Roundup Ready 
Soybean and NK603 
Cry1Ab-1 Cry1Ab delta-endotoxin specific to the sequence present in Bt176 
Cry1Ab-2 Cry1Ab delta-endotoxin specific of the sequence present in MON810 
Cry1Ab-3 Cry1Ab delta-endotoxin specific of the sequence present in Bt11, MON531 and MON15985 
Pat phosphinothricin N-acetyltransferase gene 
Maize invertase gene 
Rapeseed cruciferin gene 
Soybean lectin gene 
Plant rubiscco gene (large subunit, rbcL)
 suriV ciasoM rewolfiluaC eht fo IIIFRO VMaC
det ctl 4det ctl 4det ctl 4det ctl 4
negative hyb ctlpositive hyb ctldet ctl 9det ctl 8
SoybeanPlantnegative det ctldet ctl 7
RapeseedMaizePatdet ctl 6
Cry1Ab-3Cry1Ab-2Cry1Ab-1det ctl 5
EPSPS-2EPSPS-1CaMVdet ctl 4
Pnos-nptIIPCR ctlnegative det ctldet ctl 3
negative det ctlTnosP35Sdet ctl 2
det ctl 4negative det ctlpositive hyb ctldet ctl 1
(A)
(B)
Fig. 1 Design of the DualChip
GMO. a Each capture probe is
present in triplicate on the array.
Process controls are present on
the DualChip GMO for
checking the different steps of
detection including the PCR
(PCR ctl), the hybridisation (hyb
ctl) and the detection reactions
(det ctl). A detection curve is
constructed from a series of
labelled immobilised probes
(det ctl 1–9). The right column
contains only det ctl 4.
b Specific capture probes
present on the DualChip GMO
and their corresponding target
sequences
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NK603. Capture probe of Cry1Ab-3 allows the recognition
of a specific sequence present in Bt11, MON531 and
MON15985, while the Pat capture probe recognises the
sequence of the pat gene, which is present in several GMOs
(Bt11, T45, DAS59122, T25 and TOPAS19/2). Other
capture probes, such as EPSPS-1, Cry1Ab-1, Cry1Ab-2 are
specific to a sequence present only in one EU-accepted
GMO (GA21, Bt176, MON810, respectively). The plant
species, maize, rapeseed and soybean were detected using
species-specific genes (invertase, cruciferin and lectin
genes, respectively). The plant capture probe allows the
detection of the rbcL plant universal gene. The capture
probe of cauliflower mosaic virus (CaMV) serves as a
contamination control for the possible presence of the
virus. P35S is a promoter used in many GMO and is
present in the CaMV virus. If the P35S screening element
is detected together with the presence of CaMV, the
probability is high that the P35S signal is coming from the
virus infecting the plant and not from a GMO.
A series of controls are provided within the assay in
order to detect problems occurring during the method
process. The different steps of the assay are checked by
three positive controls: the PCR, the hybridisation and the
detection controls. When the controls are not correctly
detected, the results are discarded.
PCR
The genetic elements were amplified by four separated
PCR assays using biotinylated primers. The four different
PCR elements amplified the following elements: PCR A:
Tnos and P35S; PCR B: Pnos-nptII, CaMV and PCR
control; PCR C: Pat, Cry1A(b) and EPSPS; PCR D: con-
ventional maize, soybean, rapeseed and plant. The PCR
control is an external DNA spiked into the assay as positive
control of the amplification (inhibitors and reagents pres-
ence). The four different PCR are also performed with
nuclease-free water as negative PCR control for testing of
the possible presence of contaminating amplicons or DNA.
The PCR assays were carried out in a Mastercycler ep
gradient S (Eppendorf, Germany). Into each PCR, 100 ng
genomic DNA template was incorporated.
Detection on the array
The microarray hybridisation assays were carried out as
follows: 9 ll of PCR product from each of the four PCR
reactions were mixed with 4 ll of hybridisation control and
5 ll of SensiHyb solution. A volume of 5 ll of 0.5 N
NaOH was added and mixed. After 5 min of incubation at
room temperature, the solution was neutralised with 50 ll
of Genomic HybriBuffer and loaded into the hybridisation
chamber of the slide. The chamber was sealed with a
sealing foil and the slide incubated for 1 h at 60 C in a
Thermomixer comfort (Eppendorf, Germany) under agita-
tion at 1,000 rpm for the hybridisation. After removal of
the sealing foil and the hybridisation frame, the slides were
labelled using the Silverquant detection kit according to
the instruction manual (Eppendorf, Germany). The ampli-
fication of the colorimetric signal is based on silver
precipitation catalysed by the presence of nanogold parti-
cles. The slides were then scanned and quantified with a
Silverquant scanner (Eppendorf, Germany) and data
obtained were analysed with the Silverquant analysis
software as described in Hamels et al. [10]. The analysis
software includes the automatic removal of outliers within
the triplicates.
Experimental design of the validation
The validation protocol consisted of 12 sets of PCR and
hybridisations per laboratory. The 12 PCR were performed
in 7 days (PCR 1–7). Negative PCR controls were per-
formed in duplicate for the preliminary tests (PCR 1) and in
quadruplicates for each other PCR (PCR 2–7). Each PCR
set consisted of 4 PCR tubes (A, B, C, D) containing dif-
ferent primer pairs for the amplification of specific DNA
sequences; 9 ll of each of these four PCR was then com-
bined for hybridisation on the array in a final volume of
100 ll. In normal conditions of use of the biochips, a DNA
extract is submitted to the four different multiplex PCR (A,
B, C and D) and then, after combination of the PCR
products of tubes A to D, analysed on the biochips. In this
study for validation purposes and in order to reduce the
quantity of analyses to be performed, the 36 samples were
distributed over the four types of PCR as indicated in
Table 1. Each assay (PCR and hybridisation) for validation
was performed in quadruplicate. The workload of such a
validation study accounted for 3,360 PCR (280 PCR per
laboratory: two preliminary PCR sets and its negative PCR
control in duplicate plus ten sets distributed over 6 days
and the six corresponding negative PCR controls in qua-
druplicates) and 840 hybridisations (70 hybridisations per
laboratory).
The complete DualChip GMO technology was intro-
duced to each laboratory during a ‘‘one day demonstration’’.
The two-first sets of PCR (PCR1a and PCR1b) and
hybridisation (with sample controls ctl1 and ctl2, respec-
tively, see Table 1) were performed during the training. The
results of these preliminary assays were not part of the
evaluation data. The next experiments were then conducted
and constitute the results of the evaluation.
A non-plant DNA sample (PCR2a) was included to
evaluate the specificity of the assay (false positive results
assessment). PCR sets 3, 4, 5 and 6 tested the different
GMO concentrations. PCR set 7a tested the ability to detect
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a low concentration of a GMO (0.1% RRS) in the presence
of 100% concentration of another GMO (TOPAS19/2).
Each sample contained 100 ng of purified DNA per PCR
tube.
Acceptance criteria
One of the challenges of the validation of a multiplex assay
is to determine which statistical parameters should be taken
into consideration and the appropriate number of assays to
be performed in order to ensure the statistical significance
of the study. Since the aim of the validation was to evaluate
the significance of the detection of each specific element
having a specific capture probe on the array, the data
analysis was based on the calculation of the accuracy rate
and the confidence threshold was fixed at 95% for each
detectable element. The specificity performance (accep-
tance threshold of false positives) was fixed at 5%. In terms
of detection sensitivity, it was decided that the method
should be able to detect down to 0.1% of the GMO events
and 1% for the taxa. More specific acceptance criteria
were: overall validation is accepted if the results of at least
8 laboratories (ISO 5725 recommendation [13]) are
reported and considered as valid; the arrays with technical
deviations are removed to calculate the total percentage of
detection, each target element is validated separately; a
signal is considered as positive when its intensity is 2.5
times its standard deviation above the local background
intensity and above a threshold value of 1,500. The con-
centrations over which the method is pre-validated are, for
the screening elements, 1, 0.5, 0.1 and 0.045% GM and for
the plant species elements, 50, 5, 1 and 0.5%. The false
positive results will be determined on a non-plant DNA and
should be lower than 5%. The planning of the validation,
i.e. number of laboratories, number of samples, number of
replicates, number of GM events per sample and concen-
trations were then defined accordingly taking these
assumptions into account together with the practical fea-
sibility of the validation assay.
Results and discussion
Pre-validation
The performance criteria were first tested in a pre-valida-
tion round performed in five laboratories. One laboratory
carried out 21 replicates of each sample (1,700 PCR
reactions and 425 hybridisations). Each of the four other
laboratories analysed three replicates of each sample (240
PCR reactions and 60 hybridisations). A total of 33 repli-
cates were thus performed to assess the repeatability of the
method. The results obtained (see Table 2) showed that six
screening target elements (P35S, Tnos, Pnos-nptII, Pat,
Cry1Ab-1 and Cry1Ab-2) had a limit of detection of
0.045% expressed as mass GMO concentration with an
accuracy rate above 95%. One target element (Cry1Ab-3))
showed a detection limit of 0.1% expressed as GMO
concentration with an accuracy rate above 95%, and two
screening target elements (epsps-1 and epsps-2) had a
detection limit of 0.5% with an accuracy rate above 95%.
The four plant species targets were detected in all experi-
ments with accuracy rates above 95% (data not shown).
The absolute limit of detection of the CaMV control target
was of 50 copies per PCR. To comply with the acceptance
criteria, the capture probes of epsps-1 and epsps-2 were
Table 2 Pre-validation study of the reproducibility of the method
Sample composition in PCR tubes
GMO (1%) GMO (0.5%) GMO (0.1%) GMO
(0.045%)
CaMV
(5,000 copies)
CaMV
(500 copies)
CaMV
(50 copies)
CaMV
(10 copies)
Target
P35S 33/33 (100%) 33/33 (100%) 33/33 (100%) 33/33 (100%) – – – –
Tnos 33/33 (100%) 33/33 (100%) 33/33 (100%) 33/33 (100%) – – – –
Pnos-nptII 30/31 (97%) 30/31 (97%) 31/32 (97%) 32/33 (97%) – – – –
Pat 33/33 (100%) 33/33 (100%) 33/33 (100%) 32/33 (97%) – – – –
Cry1Ab-1 33/33 (100%) 33/33 (100%) 32/33 (97%) 32/32 (100%) – – – –
Cry1Ab-2 33/33 (100%) 32/33 (97%) 32/33 (97%) 33/33 (100%) – – – –
Cry1Ab-3 32/32 (100%) 31/31 (100%) 32/33 (97%) 30/32 (94%) – – – –
EPSPS-1 32/33 (97%) 33/33 (100%) 26/33 (79%) 21/33 (64%) – – – –
EPSPS-2 31/32 (97%) 31/32 (97%) 31/33 (94%) 30/32 (94%) – – – –
CaMV – – – – 33/33 (100%) 33/33 (100%) 32/32 (100%) 18/33 (55%)
Data are given as the number of positive outcomes per total of replicates. A total of 33 replicates were performed by the five laboratories
involved in the pre-validation study. Some data were removed due to technical problems
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changed after the pre-validation in order to reach a limit of
detection of 0.1% for all screening target elements and the
collaborative trial was then organised.
Results of the collaborative trial
The composition of the 12 experimental sets is presented in
Table 1. Each set comprised four PCR, which were then
detected on one array. The first PCR 1a and b (with sam-
ples 1 and 2, respectively) were used to introduce the
different laboratories to this new technology (demonstra-
tion part). For these preliminary tests, we followed the
protocol provided above. Mainly, the DNA samples were
processed to the four different multiplex PCR (A, B, C and
D) and the resulting amplicons were combined and ana-
lysed on the biochip. Out of 12 laboratories, 11 succeeded
in performing these preliminary assays and were incorpo-
rated into the validation assay.
A non-plant DNA sample (PCR2a, sample 3) was
included to test the specificity in terms of false positive
results. As shown in Fig. 2, only the PCR control (PCR
ctl) was effectively detected after hybridisation. This is in
line with the expectation.
In the PCR3a set (Table 1), the PCR tube A contained
primers for the amplification of P35S and Tnos DNA
fragment from the 1% Bt11 (sample 4). The PCR tube B
contained primers for the amplification of the Pnos-nptII
fragment from the 1% TOPAS19/2 (sample 8). The PCR
primers in the reaction tube C should allow the amplifi-
cation of the Cry1A(b)-3 and Pat fragments of the 1% Bt11
DNA template, the epsps-2 of the 1% RRS DNA template
and the Cry1A(b)-2 of the 1% MON810 (sample 12). The
primers in the reaction tube D should allow the amplifi-
cation of the ivr (invertase) and rbcL reference fragments
from the maize genome (sample 16). The results (Fig. 3)
show that the simultaneous hybridisation of the four dif-
ferent PCR on a single microarray allowed the detection of
all ten expected amplified markers (P35S, Tnos, PCR ctl,
Pnos-nptII, epsps-2, Cry1A(b)-2, Cry1A(b)-3, Pat, maize
and plant). Similar results were obtained with PCR3b,
PCR4a and PCR4b, which were performed with DNA
samples having the same GMO but at lower concentrations
(see Table 1).
In the PCR5a set (Table 1), the following elements were
expected to be amplified in the different PCR tubes: P35S
DNA fragment from the 1% Bt176 (tube A, sample 20),
A
B
C
D
SoybeanPlantnegative det
ctl
RapeseedMaizePat
Cry1Ab-3Cry1Ab-2Cry1Ab-1
EPSPS-2EPSPS-1CaMV
Pnos-nptIIPCR ctlnegative det
ctl
negative
det ctlTnosP35S
(A) (B)
Fig. 2 Array results for PCR2a. a A volume of 9 ll of each of the
four PCR (A, B, C and D) performed on non-plant DNA sample were
hybridised on the DualChip GMO array. PCR B allows the
amplification of a DNA fragment (PCR ctl), which is detected on
the array. Box B shows the positive signal of the PCR control. Boxes
A, C and D do not show any positive results since the PCR2a sample
contains non-plant DNA. b The location of the positive element (in
bold and italic) is indicated. ctl control, det detection
A
B
C
D
SoybeanPlantnegative det
ctl
RapeseedMaizePat
Cry1Ab-3Cry1Ab-2Cry1Ab-1
EPSPS-2EPSPS-1CaMV
Pnos-nptIIPCR ctlnegative det
ctl
negative
det ctlTnosP35S
(A) (B)Fig. 3 Array results for PCR3a.
a A volume of 9 ll of each of
the four PCR (A, B, C and D)
were hybridised on a DualChip
GMO array. Each PCR allows
the amplification of different
DNA fragments. Box A, B, C
and D show the positive signals
obtained on the array after
hybridisation of PCR products
corresponding to the PCR tubes
A, B, C and D. b The location of
the positive elements (in bold
and italic) is indicated
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CaMV fragment (500 copies of CaMV plasmid were
present in this sample) and the PCR control (tube B,
sample 24), Cry1A(b)-1 of the 1% Bt176 and the epsps-1 of
the 1% GA21 (tube C, sample 28), cruciferin, lectin and
rbcL fragments from the sample containing both rapeseed
and soybean at a concentration of 50% (tube D, sample 32).
The result (Fig. 4) shows that the simultaneous hybridisa-
tion of the four different PCR on a single microarray
allowed the detection of the eight expected amplified
markers (P35S, PCR ctl, CaMV, epsps-1, cry1Ab-1, rape-
seed, soybean and plant). PCR5b, PCR6a and PCR6b were
performed with DNA samples containing the same GMO
at lower concentrations and gave the same results (see
Table 1).
The four PCR of the PCR7a set contained the same
sample (sample 36), which is a mixture of 0.1% RRS in
100% TOPAS 19/2 (see Table 1). The following elements
were expected to be amplified in the different PCR tubes:
P35S and Tnos DNA fragments from the 0.1% RRS, P35S
from the 100% TOPAS 19/2 (tube A), Pnos-nptII fragment
from the 100% TOPAS 19/2 (tube B), Pat fragments from
the 100% TOPAS 19/2, the epsps-2 from the 0.1% RRS
(tube C), cruciferin fragment from the rapeseed DNA
template and lectin fragment from the soybean DNA
template (tube D). The results (Fig. 5) show that the
simultaneous hybridisation of the four different PCR on a
single microarray allowed the detection of the nine
expected amplified markers (P35S, Tnos, PCR ctl, Pnos-
nptII, epsps-2, Pat, rapeseed, soybean and plant) meaning
that both GM events differing by a factor of 1,000 in
concentration can be detected simultaneously with the
same criteria.
Technical deviations and removal of outliers spots
Some data obtained from experiments showing technical
deviations were removed to calculate the total percentage
of detection according to the parameters defined in the
acceptance criteria (Table 3). Four types of technical
deviations were observed. The first kind of deviation,
A
B
C
D
SoybeanPlantnegative det
ctl
RapeseedMaizePat
Cry1Ab-3Cry1Ab-2Cry1Ab-1
EPSPS-2EPSPS-1CaMV
Pnos-nptIIPCR ctlnegative det
ctl
negative
det ctlTnosP35S
(A) (B)
Fig. 4 Array results for PCR5a. a A volume of 9 ll of each of the
four PCR (A, B, C and D) were hybridised on a DualChip GMO array.
Each of PCR allows the amplification of different DNA fragments.
Box A, B, C and D show the positive signals obtained on the array
after hybridisation of PCR products corresponding to the PCR tubes
A, B, C and D. b The location of the positive elements(in bold and
italic) is indicated
A
B
C
D
SoybeanPlantnegative det
ctl
RapeseedMaizePat
Cry1Ab-3Cry1Ab-2Cry1Ab-1
EPSPS-2EPSPS-1CaMV
Pnos-nptIIPCR ctlnegative det
ctl
negative
det ctlTnosP35S
(A) (B)
Fig. 5 Array results for PCR7a. a A volume of 9 ll of each of the
four PCR reactions (A, B, C and D) were hybridised on a DualChip
GMO array. Each of PCR allows the amplification of different DNA
fragments. Box A, B, C and D show the positive signals obtained on
the array after hybridisation of PCR products corresponding to the
PCR tubes A, B, C and D. b The location of the positive elements (in
bold and italic) is indicated
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called ‘‘triplicate analysis deviation’’, occurred when two
replicates of the same array were affected by a technical
artefact. The main cause is the formation of an air bubble
during the hybridisation so that part of the array is unde-
tectable or shows a very low density (Fig. 6); of all results,
only 3.2% were affected in the analysis of triplicates. A
second observed type of technical deviation was negative
PCR controls showing a positive signal (0.84% of the total
arrays). Finally, 1.2% of the arrays did not show any signal
on the positive controls suggesting a problem in one of the
detection steps (detection, hybridisation, PCR). Two arrays
were also accidentally wiped off. Table 3 summarises the
technical deviations and the percentages of affected results.
Outliers [10] that are not covered by these technical
errors can be identified based on the ISO 5725. We applied
this norm by calculation of the binomial probability dis-
tribution of data from all laboratories for each specific
PCR. The probability of positive response was estimated
across all laboratories as the ratio of positive outcomes
over the total number of events. According to the criteria of
ISO 5725 (1994), data were identified as outliers if their
probability to belong to the same binomial population was
lower than 0.01.
Determination of the accuracy rate
The accuracy rate criterion was set for this study at 95%.
Accuracy rates assess the performance of the method on
individual genetic target elements. In order to calculate the
accuracy rate, the data were first presented as ‘‘yes’’ or
‘‘no’’ result. The binary data obtained for all the replicates
in all laboratories were then converted in percentages of
detection and the accuracy rate calculated.
The detection accuracy rates for each element and for
each PCR were collected from the 11 participating labo-
ratories and are summarised in Table 4. The detection
accuracy rates reported in the table are expressed in per-
centage of total valid assays after removal of the technical
deviations and outlying data as described above.
The detection of the GM target elements showed an
accuracy rate above the 95% confidence threshold down to
0.1% of GMO concentration for all GM targets (0.1%
corresponds to the cut-off established for the microarray).
Seven GM target elements out of nine showed an accuracy
rate above the 95% confidence threshold even at 0.045%
concentration. The cry1A(b)-3 element showed an accuracy
rate of 94.1%, while the P35S and the epsps-1 accuracy
rate were respectively 92.5 and 87.5% at the 0.045%
concentration. The level reached by these elements is not
far away from the 95% threshold and it would be of interest
to apply a fuzzy logic analysis [14] in order to evaluate the
global performance of the method. The targeted plant ref-
erence genes showed an accuracy rate above 95% down to
0.5% plant DNA concentration. For the controls, the
CaMV was detected above the accuracy rate of 95% in all
samples containing 500–20 copies (lowest number used in
the collaborative trial). No false positives were observed in
the non-plant extract (PCR2) in the absence of any plant or
GM event as proposed in the acceptance criteria. However,
a false positive signal at a rate of 5.1% for epsps-2 in one
GM plant sample and a false positive signal at a rate of
11.9% for maize in another plant sample were observed.
False positive results for epsps-2 were observed only in one
laboratory with two weak signals on four arrays. It was not
observed in the 37 other replicates of the other laboratories.
This result suggests a possible contamination of the sam-
ples during the experiments.
Conclusions
The study is the first validation performed on a multiplex
GMO detection assay. The protocol and the validation
scheme were based on different assumptions and on sta-
tistical thresholds that were set to evaluate the overall
method performance. The validation was based on the
detection performance of individual elements. The reasons
A B
Fig. 6 Example of a technical deviation due to incorrect triplicates
analysis. a Correct triplicate analysis: the arrows indicate the three
replicates of the Tnos marker. b Incorrect triplicates analysis: two
replicates of the Tnos marker, indicated by the arrows, were affected
by the presence of an air bubble in the central upper part of the array,
affecting the hybridisation but not the detection curve
Table 3 List and proportion of technical deviations observed during
the validation study
Technical deviation Percentage of
affected results (%)
Negative PCR ctl giving a positive response 0.84
Triplicate analysis deviation 3.21
Defective experimental step
PCR ctl not detected 0.44
Hybridisation ctl not detected 0.15
Detection ctl not detected 0.58
Arrays accidentally wiped off 0.29
Data arrays showing technical deviations have been removed to cal-
culate the total percentage of detection according to the parameters
defined in the acceptance criteria
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for such decision are that the elements are common to
several GM events and each element whatever the GM
event is amplified by the same primers and detected on the
same probe. However, the final conclusion of such assay
should be the presence or not of the GM event. For this
conclusion to be valid, all elements of the same event have
to fulfil the criteria as provided in this validation. This is
the reason why all elements of the assay had to be
validated.
It was decided that each element should be detected with
a 95% confidence and the specificity performance (accep-
tance threshold of false positives) was fixed at 5%. The
target detection limit of the method was fixed at 0.1%
concentration for each GMO and 1% for the plant reference
genes. The other acceptance criteria were a minimum of 8
laboratory reports on 12 considered as valid, using as data
the values for each element significantly different from the
background and excluding the technical deviations. The
validation acceptance criteria and the method performances
were set before the conduction of the validation study.
The results clearly showed that the various GM events
and reference gene targeted elements can be amplified in
separated multiplex PCR and then combined into the same
solution for hybridisation. We never encountered interac-
tion between amplicons in the hybridisation step.
Additionally, we did not observe significant influence on
the LOD of the GMO mixture composition compared to the
single assay at least until ratio of 1/1000: in a sample
containing 0.1% GMO diluted in another one at 100%, the
detections of both GMOs were correctly made with the
same 95% accuracy rate.
Probably the most important limiting factor of the
method is the risk of carry-over contaminations, which may
occur either during or before the assay. We observed some
false positive results, mostly concerning the plant species
reference genes, when a large amount of DNA of another
plant species was present in the sample. The origin of such
contamination is difficult to assert. In our experience, such
a low level of positive results would come from the pres-
ence of very low copy numbers of the contaminant,
typically in the range of 1–20 copies in the assay. In such a
case, the PCR and the detection are sometimes positive and
sometimes negative giving a typical low level of detectable
result. Contamination of PCR, especially in routine appli-
cations, is always a concern, especially in such a highly
sensitive method as this one. This is the reason why it is
recommended to limit the number of PCR cycles to 35. The
assay can be easily made more sensitive by increasing the
PCR cycles to 40, but with a higher risk of false positive
since a few contaminant copies will give a positive signal.
The design of the assay was made in such a way as to be
able to detect the 0.1% concentration. This corresponds to a
range of 40–80 copies in the PCR tube. We have seen that
the 0.045% concentration, which is below the detection
limit, was generally detected with good accuracy rate so
that the 20–40 copies are reached for most of the elements.
The lower sensitivity of the cry and epsps elements is due
to the use of degenerated primers, which limit the real
concentrations of specific primers in the PCR solution.
The method allows to detect the presence and also to
propose an identification of the event. This identification is
based on the fact that the GM event composition differs
from one another, so that the combination of positive ele-
ments in the assay allows proposing the presence of one or
a few events. The identification works best if only one GM
event is present in the sample. In complex samples unique
identity is not possible, but the method streamlines the
identification to a limited number of possible GM events.
This identification method allows the enforcement lab-
oratories to simplify the search for the GM event. Any
sample containing more than 0.1% GM will be found
positive by the present method and the proposed identity
will allow the laboratory to confirm and quantify the GM
usually by real-time PCR.
In conclusion, the results of this inter-laboratory trial
showed that the method fulfils the requirements in terms of
accuracy and detection limits. The method can be consid-
ered robust and reliable with respect to its intra- and inter-
laboratory accuracy.
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